Boston Scientific Corporation announced a contract to acquire Lumenis LTD's global surgical business from Baring Private Equity Asia. The company develops and commercializes energy-based medical products and will receive an upfront payment of USD 1.07 billion in cash.
PENTAX Medical has introduced two new argon plasma coagulation (APC) and electrosurgical platforms to its therapeutic accessories line - the ENDO ARC and ENDO PLUS.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 450
Published Date: Feb 13, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Rising geriatric population, increasing spending on healthcare and medicare services along with rising demand for minimally invasive procedures are the major factors driving the growth of the bipolar electrosurgical device market.
The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.
High cost associated with the bipolar electrosurgical devices and risk of side effects related to such devices are the challenges affecting the market growth.
The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by type, surgery, end user and, by region.
The general segmen is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.